REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,055,445 | -15.6% | 3,867,610 | -18.5% | 0.01% | -14.3% |
| Q2 2023 | $126,908,661 | +21.8% | 4,744,249 | -1.4% | 0.01% | +16.7% |
| Q1 2023 | $104,215,595 | -42.1% | 4,811,431 | -36.4% | 0.01% | +20.0% |
| Q4 2022 | $180,127,364 | +111.8% | 7,562,022 | +75.4% | 0.01% | 0.0% |
| Q3 2022 | $85,035,000 | +41.0% | 4,312,134 | +39.3% | 0.01% | +25.0% |
| Q2 2022 | $60,321,000 | -16.8% | 3,094,982 | +8.8% | 0.00% | 0.0% |
| Q1 2022 | $72,537,000 | +4.6% | 2,843,477 | +3.2% | 0.00% | +33.3% |
| Q4 2021 | $69,334,000 | -10.3% | 2,754,633 | -1.9% | 0.00% | -25.0% |
| Q3 2021 | $77,280,000 | +3.7% | 2,809,172 | +19.6% | 0.00% | 0.0% |
| Q2 2021 | $74,544,000 | -8.6% | 2,348,590 | +32.1% | 0.00% | -20.0% |
| Q1 2021 | $81,583,000 | +15.0% | 1,778,180 | -0.7% | 0.01% | +25.0% |
| Q4 2020 | $70,911,000 | +90.3% | 1,791,132 | +67.3% | 0.00% | +33.3% |
| Q3 2020 | $37,267,000 | +350.1% | 1,070,902 | +308.3% | 0.00% | +200.0% |
| Q2 2020 | $8,280,000 | +59.8% | 262,289 | +10.9% | 0.00% | – |
| Q1 2020 | $5,181,000 | – | 236,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |